34 completed, 6 recruiting, 6 terminated, 5 unknown. 60 Phase 2, 8 Phase 1, 6 Phase 3.
Follow Ulcer: new trials by email Literature Review of Ulcer trials Research Report on Ulcer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Diabetic Foot Ulcers PRFM, Standard of Care (SoC) - Diabetic Foot Ulcer (DFU), Ulcer | Phase 1 / Phase 2 | Not yet recruiting | Tiger Biosciences, LLC. | 55 | 2026-09-01 | 2026-09-25 |
| Seaweed Extract (Fucoidan) for Gut Inflammation in Ulcerative Colitis Low molecular weight fucoidan and standard care, Placebo and standard of care - Ulcerative Colitis (UC) | Phase 1 / Phase 2 | Enrolling by invitation | Allama Iqbal Medical College | 90 | 2026-08-01 | 2026-08-26 |
| A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis Etrasimod - Colitis, Ulcerative | Phase 2 | Recruiting | Pfizer | 24 | 2026-05-28 | 2026-10-26 |
| Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma Taurine - Oral Mucositis (Ulcerative) Due to Radiation, Nasopharyngeal Carcinoma (NPC) | Phase 2 | Not yet recruiting | Sun Yat-sen University | 130 | 2026-05-06 | 2026-05-05 |
| Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC) ATH-063, Placebo - Ulcerative Colitis, Inflammatory Bowel Diseases | Phase 2 | Recruiting | Athos Therapeutics Inc | 120 | 2026-04-30 | 2026-09-21 |
| Study of a Copaiba-Based Mouthwash Combined With Low-Level Laser Therapy in the Prevention of Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation Copaíba, Placebo - Oral Mucositis, Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy | Phase 2 | Recruiting | Instituto Nacional de Cancer, Brazil | 76 | 2026-03-29 | 2026-09-09 |
| Aerosolized Mesenchymal Stem Cell-Derived Exosomes for the Prevention and Treatment of Radiation-Induced Oral Mucositis mesenchymal stem cell-derived exosomes - Oral Mucositis (Ulcerative) Due to Radiation | Phase 2 | Not yet recruiting | First Affiliated Hospital of Guangxi Medical University | 200 | 2026-01-01 | 2025-12-31 |
| Copaíba-based Mouthwash in Oral Mucotitis Prevention and Treatment in Oral Cancer Patients During Radioteraphy Copaíba mouthwash, Placebo mouthwash - Oral Mucositis, Oral Mucositis (Ulcerative) Due to Radiation | Phase 2 | Withdrawn | Instituto Nacional de Cancer, Brazil | 2025-01-17 | 2026-10-09 | |
| Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma propranolol - Infantile Hemangioma | Phase 2 / Phase 3 | Recruiting | West China Hospital | 32 | 2025-01-01 | 2026-09-21 |
| Telacebec (T) Treatment in Adults With Buruli Ulcer (BU). (TREAT BU) Telacebec - Buruli Ulcer | Phase 2 | Recruiting | Barwon Health | 200 | 2024-07-09 | 2026-06-30 |
| Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients. N-Acetyl-Cysteine with Institutional standard care, Institutional standard care - Oral Mucositis (Ulcerative) Due to Radiation | Phase 2 | Recruiting | Mansoura University | 50 | 2024-04-04 | 2025-01-15 |
| Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients Chinese Medicine Oral Rinse Formula-I (CMORF-I), Standard Care, Placebo - Head and Neck Neoplasms, Oral Mucositis (Ulcerative) Due to Radiation | Phase 1 / Phase 2 | Unknown | Chinese University of Hong Kong | 40 | 2023-01-31 | 2022-12-27 |
| Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC) PL8177 Placebo, PL8177 - Ulcerative Colitis, Ulcerative Colitis Acute | Phase 2 | Active not recruiting | Palatin Technologies, Inc | 16 | 2022-09-15 | 2025-03-05 |
| Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study. Herbal gargle, Normal saline - Head and Neck Neoplasms, Chemoradiotherapy | Phase 2 | Unknown | Chang Gung Memorial Hospital | 80 | 2022-04-15 | 2022-04-22 |
| A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Ulcerative Colitis GLPG3970, Placebo - Ulcerative Colitis | Phase 2 | Completed | Lakefront Biotherapeutics NV | 31 | 2020-10-05 | 2023-01-27 |
| Intra-oral Treatment of OLP With Rivelin®-CLO Patches Clobetasol Propionate - Oral Lichen Planus | Phase 2 | Completed | Dermtreat | 140 | 2018-06-28 | 2020-07-14 |
| Topical Sodium Nitrite in Sickle Cell Disease and Leg Ulcers Topical Sodium Nitrite, Placebo - Sickle Cell Disease | Phase 2 | Terminated | caterina P minniti | 18 | 2018-04-06 | 2025-05-07 |
| Melatonin for Prevention of Radiation Induced Oral Mucositis Rapid Release Capsules Melatonin, 10 mg, Miconaz oral gel, BBC oral spray - Oral Mucositis (Ulcerative) Due to Radiation | Phase 2 | Completed | Hams Hamed Abdelrahman | 40 | 2018-01-12 | 2019-06-17 |
| Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease Subcutaneous Ustekinumab - Behçet Disease | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 16 | 2017-06-14 | 2025-09-08 |
| Study of VF001-DP in Patients With Chronic Venous Leg Ulcers Placebo, VF001-DP LD, VF001-DP HD - Ulcer, Leg Ulcer | Phase 2 | Unknown | Factor Therapeutics Ltd. | 156 | 2016-11-01 | 2018-09-25 |
Showing 20 of 60. Sign in to see all of them.
Diabetic Foot (12) · Stomatitis (10) · Wounds and Injuries (8) · Colitis, Ulcerative (7) · Colitis (6) · Varicose Ulcer (6) · Diabetes Mellitus (5) · Infections (4) · Ischemia (4) · Burns (3) · Inflammatory Bowel Diseases (3) · Peripheral Vascular Diseases (3) · Abscess (2) · Arterial Occlusive Diseases (2)
Pathological Conditions, Signs and Symptoms (60) · Pathologic Processes (59) · Skin and Connective Tissue Diseases (28) · Skin Diseases (24) · Cardiovascular Diseases (21) · Vascular Diseases (20) · Skin Ulcer (19) · Leg Ulcer (17) · Endocrine System Diseases (14) · Diabetes Complications (12) · Diabetic Angiopathies (12) · Mouth Diseases (12) · Stomatognathic Diseases (12) · Diabetic Neuropathies (11) · Foot Ulcer (11)
Standard of Care (7) · Saline Solution (3) · Acyclovir (2) · Levofloxacin (2) · Vancomycin (2) · telavancin (2) · Acetylcysteine (1) · Adrenergic beta-Antagonists (1) · Analgesia (1) · Anti-Inflammatory Agents, Non-Steroidal (1) · Bleomycin (1) · Clobetasol (1) · Collagenases (1) · Doxycycline (1) · Electrochemotherapy (1)
OcuNexus Therapeutics, Inc. (3) · Chinese University of Hong Kong (2) · Cumberland Pharmaceuticals (2) · Instituto Nacional de Cancer, Brazil (2) · PluroGen Therapeutics, Inc (2) · Allama Iqbal Medical College (1) · Allergan (1) · AnGes USA, Inc. (1) · Arava Bio Tech Ltd. (1) · Assistance Publique - Hôpitaux de Paris (1) · Athos Therapeutics Inc (1) · Azidus Brasil (1) · Barwon Health (1) · Beijing Northland Biotech. Co., Ltd. (1) · Centers for Disease Control and Prevention (1)
United States (30) · China (5) · Australia (4) · Canada (4) · United Kingdom (4) · Brazil (3) · Denmark (3) · Germany (3) · Israel (3) · Japan (3) · Egypt (2) · France (2) · New Zealand (2) · Poland (2) · Russia (2)
G. Ralph Corey, MD (2) · Andres Gutierrez, M.D., Ph.D. (1) · Arthur Tucker, PhD (1) · C. Mauli Agrawal, Ph.D. (1) · Caterina Minniti, M.D. (1) · Daniel O'Brien, MD (1) · David G Armstrong, DPM MD PhD (1) · David Lewis, MD (1) · David Prior (1) · David T. Rubin, M.D. (1) · David T. Rubin, MD (1) · Eglal M Moussa, Phd (1) · Fahimeh Anbari, resident (1) · Fatma Gharib Khirallah, Associate Professor (1)
PMID 11240232, PMID 15108222, PMID 15159012, PMID 15287078, PMID 15504999, PMID 16004814, PMID 16415901, PMID 16884839, PMID 16950583, PMID 18325386, PMID 18407446, PMID 18485252, PMID 18623174, PMID 18973181, PMID 19530940, PMID 19711453, PMID 19715417, PMID 20443734, PMID 20668585, PMID 21146749, PMID 21864666, PMID 22114446, PMID 22659765, PMID 22877866, PMID 22923859, PMID 23046006, PMID 23052923, PMID 23469127, PMID 23685937, PMID 24311846, PMID 24471119, PMID 24760263, PMID 25052044, PMID 25272640, PMID 25497988, PMID 25562805, PMID 25858507, PMID 26257818, PMID 27301877, PMID 27469197, PMID 27865796, PMID 28590441, PMID 29966612, PMID 30117204, PMID 31030097, PMID 31736742, PMID 31858338, PMID 32056010, PMID 32106571, PMID 32148535
2025 (1), R01AR045506 (1), R01DK059961 (1), R44DK059074 (1)